Companies House 2025-02-01 2026-01-31 false 15454219 2026-01-31 15454219 2025-02-01 2026-01-31 15454219 2024-01-30 2025-01-31 15454219 uk-bus:Director1 2025-02-01 2026-01-31 15454219 uk-bus:Director2 2025-02-01 2026-01-31 15454219 2025-02-01 2026-01-31 15454219 uk-bus:Micro-entities 2025-02-01 2026-01-31 15454219 uk-bus:FullAccounts 2025-02-01 2026-01-31 15454219 uk-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 15454219 2025-01-31 15454219 uk-core:WithinOneYear 2026-01-31 15454219 uk-core:WithinOneYear 2025-01-31 15454219 uk-core:AfterOneYear 2026-01-31 15454219 1 2025-02-01 2026-01-31 15454219 2 2025-02-01 2026-01-31 15454219 uk-core:AfterOneYear 2025-01-31 iso4217:GBP

Registered Number 15454219

NEWMED PHARMA LTD

Micro-entity Accounts

31 January 2026

## NEWMED PHARMA LTD Registered Number 15454219

## Micro-entity Balance Sheet as at 31 January 2026

| Notes | 2026 | 2025
--- | --- | --- | ---
|  | £ | £
Current Assets |  | 1 | 1
Creditors: amounts falling due within one year |  | (200) | (100)
Net current assets (liabilities) |  | (199) | (99)
Total assets less current liabilities |  | (199) | (99)
Total net assets (liabilities) |  | (199) | (99)
Capital and reserves |  | (199) | (99)

- For the year ending 31 January 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
- The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 19 February 2026

And signed on their behalf by:
Bukola Rasheedat OYE, Director

## NEWMED PHARMA LTD Registered Number 15454219

## Notes to the Micro-entity Accounts for the period ended 31 January 2026

1 Employees

| 2026 | 2025
--- | --- | ---
Average number of employees during the period | 1 | 1